CompletedNot Applicable

Antenatal Breastmilk Expression From Week 34 of Gestation

Denmark60 participantsStarted 2022-08-31

Plain-language summary

In this pilot study, the investigators aim to examine if antenatal breastmilk expression from week 34 of pregnancy is a safe and feasible procedure for the mother and fetus. Furthermore, the investigators want to evaluate breastfeeding rates.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Healthy nulliparous women with no major chronic or pregnancy related diseases
✓. BMI \<27
✓. Danish speaking
✓. Singleton pregnancies
✓. Planning to exclusively breastfeed their infants and deliver at Odense University Hospital (Odense and Svendborg)

Exclusion criteria

✕. Suspected fetal intrauterine growth restriction or known major fetal anomaly
✕. Women at risk of preterm birth with one of the following diagnoses: Placenta previa, premature preterm rupture of membranes (PPROM) or previous cervical conization
✕. Women taking medications where breastfeeding is contraindicated
✕. Women with prior breast surgery: Breast reductive surgery or breast implants

What they're measuring

Gestational age at birth in the two groups

Timeframe: Through study completion, an avarage of 1 year.

Trial details

NCT IDNCT05516199

SponsorOdense University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-09-30

View on ClinicalTrials.gov More Breastmilk Expression trials